As of Feb 17
| -0.055 / -0.32%|
The 12 analysts offering 12-month price forecasts for Horizon Pharma PLC have a median target of 25.50, with a high estimate of 42.00 and a low estimate of 21.00. The median estimate represents a +50.31% increase from the last price of 16.97.
The current consensus among 12 polled investment analysts is to Buy stock in Horizon Pharma PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.